{"id":"W4416634708","doi":"10.5256/f1000research.145159.r183160","title":"Referee report. For: The identification of high-performing antibodies for Profilin-1 for use in Western blot, immunoprecipitation and immunofluorescence [version 1; peer review: 1 approved, 1 approved with reservations]","year":2023,"lang":"en","type":"article","venue":"Faculty of 1000 Research Ltd","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Genentech; Government of Canada; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Mitacs; Ontario Genomics; Genome Canada; Bayer; Motor Neurone Disease Association; Pfizer; Bristol-Myers Squibb","keywords":"Immunoprecipitation; Immunofluorescence; Identification (biology); Antibody; Monoclonal antibody; Indirect immunofluorescence","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006285847,0.0008686164,0.001388469,0.002863671,0.003487093,0.003051565,0.002610843,0.006646818,0.4724984],"category_scores_gemma":[0.07916605,0.0005577254,0.001152361,0.002241204,0.0007902036,0.002180672,0.002439174,0.00437102,0.3180913],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003399774,"about_ca_system_score_gemma":0.005126508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0245438,"about_ca_topic_score_gemma":0.03826509,"domain_scores_codex":[0.9950902,0.0006491631,0.0006002506,0.0005908093,0.002715522,0.000353923],"domain_scores_gemma":[0.912075,0.01195471,0.001256625,0.003926348,0.06821913,0.002568154],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000009110301,0.0000103012,0.00003708181,0.00003604548,0.000001812988,0.00004260876,0.00001440036,0.000006184819,0.0001240846,0.0002318763,0.9962203,0.003266279],"study_design_scores_gemma":[0.00002031839,0.00001640012,0.0009993896,0.00009586287,0.000009488153,0.0001619376,0.0001256286,0.00007895315,0.0003552313,0.001041363,0.9970626,0.00003289154],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"commentary","genre_scores_codex":[0.001112626,0.00333785,0.00690329,0.3545078,0.4233627,0.002269312,0.0321972,0.005961955,0.1703472],"genre_scores_gemma":[0.005952241,0.002198841,0.005554067,0.07896437,0.04188634,0.001214573,0.01000335,0.001737731,0.8524884],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.9937142,"threshold_uncertainty_score":0.752417,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1098088807381378,"score_gpt":0.4100936131978792,"score_spread":0.3002847324597415,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}